• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与聚电解质尤特奇E100络合的非甾体抗炎药水分散体的平衡和释放特性

Equilibrium and release properties of aqueous dispersions of non-steroidal anti-inflammatory drugs complexed with polyelectrolyte eudragit e 100.

作者信息

Quinteros Daniela Alejandra, Allemandi Daniel Alberto, Manzo Ruben Hilario

机构信息

Departamento de Farmacia, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, CP 5000, Argentina.

出版信息

Sci Pharm. 2012 Apr-Jun;80(2):487-96. doi: 10.3797/scipharm.1107-17. Epub 2012 Apr 30.

DOI:10.3797/scipharm.1107-17
PMID:22896833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3383216/
Abstract

Equilibria and release properties of aqueous systems consisting of a set of five non-steroidal anti-inflammatory drugs (AH) complexed with the cationic polymethacrylate Eudragit E 100 (EU) are reported in this study. The composition (EU(AH)(50) (HCl)(50)) having fifty mole percent of each counterion (A(-) and Cl(-)) produces clear, stable aqueous dispersions in which a remarkably high proportion of AH (higher than 98%) is condensed with the PE under the form of ion pairs. This property expands the interval of pH in which AH are aqueous soluble. The set of AH contains members with and without an alpha methyl group (-(CH(3))CH-COOH: Flurbiprofen, Naproxen, Ketoprofen) and (-CH(2)-COOH: Diclofenac, Indomethacin). The proportion of ion pairs in the complexes was lower in the former group. Release of AH from the complexes toward a saline (NaCl 0.9%) solution was assayed in Franz cells. The five complexes behaved as drug carriers that exhibited a slow drug release with a remarkable zero order. In line with the percentages of counterionic condensation observed, release rates from -(CH(3))CH-COOH complexes were clearly higher than those of -CH(2)-COOH ones.

摘要

本研究报道了由一组五种非甾体抗炎药(AH)与阳离子聚甲基丙烯酸酯Eudragit E 100(EU)络合而成的水性体系的平衡和释放特性。含有每种抗衡离子(A⁻和Cl⁻)各五十摩尔百分比的组合物(EU(AH)(50) (HCl)(50))可产生澄清、稳定的水性分散体,其中相当高比例(高于98%)的AH以离子对的形式与PE缩合。这一特性扩展了AH可溶于水的pH区间。该组AH包括含有和不含有α-甲基的成员(-(CH(3))CH-COOH:氟比洛芬、萘普生、酮洛芬)和(-CH(2)-COOH:双氯芬酸、吲哚美辛)。前一组络合物中离子对的比例较低。在Franz扩散池(Franz cells)中测定了AH从络合物向盐溶液(0.9% NaCl)的释放。这五种络合物表现为药物载体,呈现出缓慢的药物释放且具有显著的零级释放特性。与观察到的抗衡离子缩合百分比一致,-(CH(3))CH-COOH络合物的释放速率明显高于-CH(2)-COOH络合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c082/3383216/933a47018e06/scipharm-2012-80-487f3b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c082/3383216/c2d6f4cfdcb3/scipharm-2012-80-487f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c082/3383216/d17c423bf4a0/scipharm-2012-80-487f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c082/3383216/86346bf08f3f/scipharm-2012-80-487f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c082/3383216/933a47018e06/scipharm-2012-80-487f3b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c082/3383216/c2d6f4cfdcb3/scipharm-2012-80-487f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c082/3383216/d17c423bf4a0/scipharm-2012-80-487f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c082/3383216/86346bf08f3f/scipharm-2012-80-487f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c082/3383216/933a47018e06/scipharm-2012-80-487f3b.jpg

相似文献

1
Equilibrium and release properties of aqueous dispersions of non-steroidal anti-inflammatory drugs complexed with polyelectrolyte eudragit e 100.与聚电解质尤特奇E100络合的非甾体抗炎药水分散体的平衡和释放特性
Sci Pharm. 2012 Apr-Jun;80(2):487-96. doi: 10.3797/scipharm.1107-17. Epub 2012 Apr 30.
2
Interaction between a cationic polymethacrylate (Eudragit E100) and anionic drugs.阳离子聚甲基丙烯酸酯(Eudragit E100)与阴离子药物之间的相互作用。
Eur J Pharm Sci. 2008 Jan;33(1):72-9. doi: 10.1016/j.ejps.2007.10.002. Epub 2007 Oct 23.
3
Enhanced intestinal permeability and oral bioavailability of enalapril maleate upon complexation with the cationic polymethacrylate Eudragit E100.马来酸依那普利与阳离子型聚丙烯酸树脂 Eudragit E100 形成复合物后可增强其肠道通透性并提高其口服生物利用度。
Eur J Pharm Sci. 2014 May 13;55:1-11. doi: 10.1016/j.ejps.2014.01.001. Epub 2014 Jan 20.
4
Development of extended-release solid dispersions of nonsteroidal antiinflammatory drugs with aqueous polymeric dispersions: optimization of drug release via a curve-fitting technique.非甾体抗炎药与水性聚合物分散体的缓释固体分散体的研制:通过曲线拟合技术优化药物释放
Pharm Res. 1992 Feb;9(2):206-10. doi: 10.1023/a:1018933306162.
5
Ocular delivery of flurbiprofen based on Eudragit(®) E-flurbiprofen complex dispersed in aqueous solution: preparation, characterization, in vitro corneal penetration, and ocular irritation.基于分散于水溶液中的Eudragit(®)E - 氟比洛芬复合物的氟比洛芬眼部给药:制备、表征、体外角膜渗透及眼部刺激性
J Pharm Sci. 2014 Dec;103(12):3859-3868. doi: 10.1002/jps.24153. Epub 2014 Oct 7.
6
Eudragit E100 as a drug carrier: the remarkable affinity of phosphate ester for dimethylamine.Eudragit E100 作为药物载体:磷酸酯对二甲胺的显著亲和力。
Mol Pharm. 2012 Sep 4;9(9):2424-33. doi: 10.1021/mp300282f. Epub 2012 Aug 1.
7
[Anti-inflammatory effects and aqueous humor concentration of various nonsteroidal anti-inflammatory drugs in extracapsular cataract surgery].[各种非甾体类抗炎药在白内障囊外摘除术中的抗炎作用及房水浓度]
Klin Monbl Augenheilkd. 1996 Mar;208(3):161-6. doi: 10.1055/s-2008-1035191.
8
Reduced food interaction and enhanced gastrointestinal tolerability of a new system based on risedronate complexed with Eudragit E100: Mechanistic approaches from in vitro and in vivo studies.基于利塞膦酸盐与尤特奇E100络合的新系统降低食物相互作用并增强胃肠道耐受性:来自体外和体内研究的机制探讨
Eur J Pharm Biopharm. 2016 Oct;107:263-72. doi: 10.1016/j.ejpb.2016.07.012. Epub 2016 Jul 12.
9
Equilibrium and release properties of hyaluronic acid-drug complexes.透明质酸-药物复合物的平衡和释放特性。
Eur J Pharm Sci. 2013 Jul 16;49(4):588-94. doi: 10.1016/j.ejps.2013.04.023. Epub 2013 May 6.
10
Design and evaluation of pH modulated controlled release matrix systems for colon specific delivery of indomethacin.用于吲哚美辛结肠特定递送的pH调节控释基质系统的设计与评价
Pharmazie. 2008 Oct;63(10):736-42.

引用本文的文献

1
In vitro-in vivo evaluation of xanthan gum and eudragit inter polyelectrolyte complex based sustained release tablets.基于黄原胶和丙烯酸树脂的聚电解质复合物缓释片的体外-体内评价
Int J Pharm Investig. 2015 Jan-Mar;5(1):65-72. doi: 10.4103/2230-973X.147236.

本文引用的文献

1
Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion.制备布洛芬颗粒热熔挤出的口腔崩解片(ODTs)的开发和评价。
Colloids Surf B Biointerfaces. 2011 Sep 1;86(2):275-84. doi: 10.1016/j.colsurfb.2011.04.007. Epub 2011 Apr 13.
2
Interaction between a cationic polymethacrylate (Eudragit E100) and anionic drugs.阳离子聚甲基丙烯酸酯(Eudragit E100)与阴离子药物之间的相互作用。
Eur J Pharm Sci. 2008 Jan;33(1):72-9. doi: 10.1016/j.ejps.2007.10.002. Epub 2007 Oct 23.
3
Characteristics of interpolyelectrolyte complexes of Eudragit E100 with Eudragit L100.
丙烯酸树脂E100与丙烯酸树脂L100的聚电解质复合物的特性
J Control Release. 2005 Mar 2;103(1):191-8. doi: 10.1016/j.jconrel.2004.11.031. Epub 2005 Jan 13.
4
A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic, suspending and expanding agent.一种以阿拉伯胶作为渗透剂、助悬剂和膨胀剂的水不溶性药物单层渗透片系统。
J Control Release. 2003 Oct 30;92(3):375-82. doi: 10.1016/s0168-3659(03)00371-7.
5
Mechanism of lidocaine release from carbomer-lidocaine hydrogels.利多卡因从卡波姆 - 利多卡因水凝胶中的释放机制。
J Pharm Sci. 2002 Jan;91(1):267-72. doi: 10.1002/jps.10036.
6
Sustained release ketoprofen microparticles with ethylcellulose and carboxymethylethylcellulose.含乙基纤维素和羧甲基乙基纤维素的酮洛芬缓释微粒
J Control Release. 2001 Aug 10;75(3):271-82. doi: 10.1016/s0168-3659(01)00399-6.